Supporting your biologics development process
We have a wide range of experience in the analytics of biomolecules and are able to offer tailor made services as well as method qualification and transfer.
You want to learn more about how we can support your drug development?
Biomolecules expertise
BIOSIMILAR REVIEW
VelaLabs’ expertise covers a variety of biomolecules including biosimilars. The Biosimilar Review shows a market overview and can be downloaded free of charge below.
FACT SHEETS
These fact sheets will show you VelaLab's analytical portfolio in the area of biomolecules.
You will also get information about the mode of action, patent status, market, originator and research status of these selected biosimilars, antibodies, mabs and hormones:
- Abatacept
- Adalimumab
- Aflibercept
- Alemtuzumab
- Bevacizumab
- Cetuximab
- Darbepoetin alfa
- Denosumab
- Eculizumab
- Epoetin alfa
- Etanercept
- FSH
- G-CSF
- Golimumab
- HGH
- Infliximab
- Insulin
- Interferon-beta-1a
- Ipilimumab
- Natalizumab
- Nivolumab
- Omalizumab
- PegG-CSF
- Pembrolizumab
- Pertuzumab
- PTH
- Ramucirumab
- Ranibizumab
- Rituximab
- Tocilizumab
- Trastuzumab
- Ustekinumab
COMPETITIVE REPORT:
As we know the market, we have a competitive field available for all of these biomolecules:
the competitive fields are researched with state-of-the-art methods and are routinely updated.
These analysis are available upon request - see an example for a competitive field for adalimumab in our Biosimilar Review
Biosimilars approved - USA & EU
Table 1: Biosimilars approved in USA
| Product name | Manufacturer |
| Adalimumab | (launch delayed until 2023) |
| Amjevita® | Amgen |
| Cyltezo® | Boehringer Ingelheim |
| Hadlima® | Samsung Bioepis, Biogen |
| Hyrimoz® | Sandoz |
| Abrilada® | Pfizer |
| Yusimry® | Coherus |
| Yuflyma® | Celltrion |
| Bevacizumab | |
| Mvasi® | Amgen, Allergan |
| Zirabev® | Pfizer |
| Alymsys® | Amneal Pharmaceuticals |
| Vegzelma® | Celltrion |
| Epoetin alfa | |
| Retacrit® | Pfizer, Hospira |
| Etanercept | |
| Erelzi® | Sandoz |
| Eticovo® | Samsung Bioepis, Merck |
| Filgrastim | |
| Nivestym® | Pfizer |
| Zarxio® | Sandoz |
| Releuko® | Amneal Pharmaceuticals / Kashiv Biosciences |
| Infliximab | |
| Inflectra® | Pfizer, Hospira |
| Ixifi® | Pfizer (not launched) |
| Renflexis® | Samsung Bioepis |
| Avsola® | Amgen |
| Insulin | |
| Admelog® | Sanofi |
| Basaglar® | Eli Lilly, Boehringer Ingelheim |
| Rezvoglar® | Eli Lilly |
| Semglee® | Mylan, USA / Biocon, India |
| Pegfilgrastim | |
| Fulphila® | Biocon, Mylan |
| Udenyca® | Coherus |
| Ziextenzo® | Sandoz |
| Nyvepria® | Pfizer |
| Fylnetra™ | Amneal Pharmaceuticals / Kashiv |
| Stimufend® | Fresenius Kabi |
| Ranibizumab | |
| Byooviz® | Samsung Bioepis / Biogen |
| Cimerli® | Formycon / Bioeq |
| Rituximab | |
| Truxima® | Celltrion |
| Ruxiene® | Pfizer |
| Riabni® | Amgen |
| Trastuzumab | |
| Ogivri® | Biocon, Mylan |
| Ontruzant® | Samsung Bioepis / Merck |
| Herzuma® | Celltrion / Teva |
| Trazimera® | Pfizer |
| Kanjinti® | Amgen |
Table 2: Biosimilars approved in EU
| Product name | Manufacturer |
| Adalimumab | |
| Amgevita®
Solymbic® |
Amgen |
| Cyltezo® | Boehringer Ingelheim (not marketed) |
| Imraldi® | Samsung Bioepis |
| Halimatoz® / Hefya® / Hyrimoz® | Sandoz |
| Hulio® | Mylan |
| Idacio® / Kromeya® | Fresenius Kabi |
| Amsparity® | Pfizer |
| Hukyndra® / Libmyris® | Alvotech |
| Yuflima® | Celltrion |
| Aflibercept | |
| Yesafili® | Biocon |
| Bevacizumab | |
| Mvasi® | Amgen |
| Zirabev® | Pfizer |
| Aybintio® / Onbevzi® | Samsung Bioepis |
| Alymsys® | mAbxience |
| Oyavas® | Stada Arzneimittel |
| Abevmy® / Lextemy® | Mylan (now Viatris); collaboration with Biocon |
| Vegzelma | Celltrion |
| Eculizumab | |
| Bekemv® | Amgen |
| Epysqli® | Samsung Bioepis |
| Epoetin | |
| Abseamed® | Medice Arzneimittel Pütter |
| Epoetin alfa Hexal® | Hexal |
| Binocrit® | Sandoz |
| Retacrit® | Hospira |
| Silapo® | Stada Arzneimittel |
| Etanercept | |
| Benepali® | Samsung Bioepis |
| Erelzi® | Sandoz |
| Nepexto® | Mylan |
| Filgrastim | |
| Accofil® | Accord Healthcare |
| Biograstim® | CT Arzneimittel |
| Filgrastim Hexal® | Hexal |
| Filgrastim Ratiopharm®
Ratiograstim® |
Ratiopharm |
| Grastofil® | Apotex |
| Nivestim® | Hospira / Pfizer |
| Tevagrastim® | Teva |
| Zarzio® | Sandoz |
| Follitropin alfa | |
| Bemfola® | Finox Biotech |
| Ovaleap® | Teva |
| Infliximab | |
| Flixabi® | Samsung Bioepis |
| Inflectra® | Hospira |
| Remsima® | Celltrion |
| Zessly® | Sandoz |
| Insulin | |
| Abasaglar® | Eli Lilly, Boehringer Ingelheim |
| Insulin lispro® | Sanofi |
| Lusduna® | MSD |
| Semglee® | Mylan |
| Insulin Aspart | Sanofi |
| Kixelle® (Insulin aspart) | Mylan |
| Pegfilgrastim | |
| Pelgraz® | Accord Healthcare (Intas) |
| Udenyca® | Coherus |
| Fulphila® | Biocon / Mylan |
| Pelmeg® | Cinfa / Mundipharma |
| Cegfila® | Mundipharma |
| Ziextenzo® | Sandoz |
| Grasustek™ | Juta Pharma/ USV |
| Stimufend® | Fresenius Kabi |
| Ranibizumab | |
| Byooviz® | Samsung Bioepis / Biogen |
| Ranivisio® | Formycon / Polpharma |
| Ximluci® | Stada Arzneimittel / Xbrane |
| Rituximab | |
| Blitzima®
Ritemvia® Rituzena® Truxima® |
Celltrion |
| Rixathon®
Riximyo® |
Sandoz |
| Somatropin | |
| Omnitrope® | Sandoz |
| Teriparatide | |
| Movymia® | Stada Arzneimittel |
| Terrosa® | Gedeon Richter |
| Livogiva® | Theramex |
| Qutavina® | EuroGenerix |
| Sondelbay® | Accord Healthcare |
| Trastuzumab | |
| Herzuma® | Celltrion |
| Ontruzant® | Samsung Bioepis |
| Kanjinti® | Amgen |
| Trazimera® | Pfizer |
| Ogivri® | Mylan |
| Zercepac® | Shanghai Henlius / Accord Healthcare |